rediff.com
e.g. Tata motors, Reliance MF, 500570
Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 3.09 3.09 3.09 3.09 3.09
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 61.91 60.05 43.73 26.55 21.21
Loan funds
Secured loans 8.45 18.66 7.52 8.79 9.10
Unsecured loans - - - - -
Total 73.45 81.80 54.34 38.43 33.40
Uses of funds
Fixed assets
Gross block 16.53 16.17 14.81 13.93 11.36
Less : revaluation reserve - - - - -
Less : accumulated depreciation 5.81 5.47 4.83 4.52 4.18
Net block 10.72 10.70 9.99 9.40 7.19
Capital work-in-progress - - - - 1.08
Investments 2.93 1.88 0.01 - -
Net current assets
Current assets, loans & advances 108.09 103.57 74.62 47.99 50.08
Less : current liabilities & provisions 48.28 34.35 30.27 18.97 24.95
Total net current assets 59.80 69.22 44.35 29.03 25.13
Miscellaneous expenses not written - - - - -
Total 73.45 81.80 54.34 38.43 33.40
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments 0.01 0.01 0.01 - -
Contingent liabilities 0.07 0.07 0.07 0.07 0.07
Number of equity sharesoutstanding (Lacs) 30.90 30.90 30.90 30.90 30.90
Close
Add Samrat Pharmachem Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Samrat Pharmachem Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close